These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22251279)

  • 1. Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-alcoholic fatty liver disease.
    Masuda K; Ono M; Fukumoto M; Hirose A; Munekage K; Ochi T; Okamoto N; Akagi N; Ogawa Y; Saibara T
    Hepatol Res; 2012 Mar; 42(3):273-9. PubMed ID: 22251279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of (99m)Tc-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice.
    Rokugawa T; Uehara T; Higaki Y; Matsushima S; Obata A; Arano Y; Abe K
    EJNMMI Res; 2014 Dec; 4(1):57. PubMed ID: 26116119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of
    Norouzi G; Nikdel S; Pirayesh E; Salimi Y; Amoui M; Haghighatkhah H; Ghodsi Rad MA; Javanijouni E; Khoshbakht S
    Cancer Biother Radiopharm; 2023 Dec; 38(10):663-669. PubMed ID: 36576502
    [No Abstract]   [Full Text] [Related]  

  • 4. Utility of quantitative 99mTc-phytate scintigraphy to diagnose early-stage non-alcoholic steatohepatitis.
    Kikuchi M; Tomita K; Nakahara T; Kitamura N; Teratani T; Irie R; Yokoyama H; Suzuki T; Yokoyama T; Taguchi T; Tanaka S; Noguchi M; Ohkura T; Hibi T
    Scand J Gastroenterol; 2009; 44(2):229-36. PubMed ID: 18819037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: a 2D speckle tracking imaging study.
    Kocabay G; Karabay CY; Colak Y; Oduncu V; Kalayci A; Akgun T; Guler A; Kirma C
    Clin Sci (Lond); 2014 Feb; 126(4):297-304. PubMed ID: 23947743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study.
    Eriksen PL; Thomsen KL; Larsen LP; Grønbaek H; Vilstrup H; Sørensen M
    Aliment Pharmacol Ther; 2019 Jul; 50(1):84-92. PubMed ID: 31099410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
    Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
    Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.
    Ooi GJ; Burton PR; Earnest A; Laurie C; Kemp WW; Nottle PD; McLean CA; Roberts SK; Brown WA
    Obes Surg; 2018 Feb; 28(2):427-436. PubMed ID: 28776153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
    Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis.
    Suzuki K; Kirikoshi H; Yoneda M; Mawatari H; Fujita K; Nozaki Y; Takahashi H; Abe Y; Inamori M; Shimamura T; Kobayashi N; Kubota K; Saito S; Nakajima A
    Hepatol Res; 2010 Jul; 40(7):693-700. PubMed ID: 20412325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
    Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
    Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
    J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.